Novartis Settles Class Action Gender Discrimination for $152 Million

Seeking to put an end to the landmark discrimination verdict, Novartis and the plaintiffs representing the 5,600 women who worked there from 2002 until 2007 agreed to settle the case for $152 million, with an additional promise to spend $22.5 million over three years to improve its policies.

The fairness hearing is set for November 19. We’ll bring you the update as soon as we have it.